Vault-13

MEDICUS PHARMA LTD MDCXW

*W EXP 11/15/202 · Equity WRT · CUSIP 58471K111

4 institutional holders -2 vs Q1 2026
111,203111.2k shares reported held*
$63.6kreported value*
0 new 1 added 1 reduced 2 sold out net sold ≈ $61.8k (-102.8k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.57.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0510Q4 24: 7Q1 25: 8Q2 25: 6Q3 25: 5Q4 25: 5Q1 26: 6Q2 26: 44Q4 24Q2 25Q4 25Q2 26
Numbers
QuarterHolders
Q4 20247
Q1 20258
Q2 20256
Q3 20255
Q4 20255
Q1 20266
Q2 20264

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
505Q1 25: 5 bought or addedQ1 25: 1 cut or sold outQ1 25Q2 25: 1 bought or addedQ2 25: 3 cut or sold outQ2 25Q3 25: 1 bought or addedQ3 25: 1 cut or sold outQ3 25Q4 25: 1 bought or addedQ4 25: 1 cut or sold outQ4 25Q1 26: 2 bought or addedQ1 26: 0 cut or sold outQ1 26Q2 26: 1 bought or addedQ2 26: 3 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q1 202551
Q2 202513
Q3 202511
Q4 202511
Q1 202620
Q2 202613

Biggest buyers

UBS Group AG Added +738+738

Biggest sellers

Private Advisor Group, LLC Sold out -49,000-49.0k
Anson Funds Management LP Reduced -42,400-42.4k
Empery Asset Management, LP Sold out -12,100-12.1k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

No one currently above 5% in the filings since 19 Dec 2024.

Fell to 5% or below in the last year: Melani Kenneth R. (3.6%, 2026-10-16)

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported since 1 Apr 2026.

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 ARMISTICE CAPITAL, LLC 0.00% of their portfolio NEW YORK, NY 60,60060.6k $39.4k $39.4k 0.00% Unchanged
2 Anson Funds Management LP 0.00% of their portfolio DALLAS, TX 42,40042.4k $18.9k $18.9k 0.00% Reduced -42.4k -42,400
3 Connective Capital Management, LLC 0.00% of their portfolio PALO ALTO, CA 6,0006.0k $3.9k $3.9k 0.00% Unchanged
4 UBS Group AG 0.00% of their portfolio ZURICH, V8 2,2032.2k $1.4k $1.4k 0.00% Added +738 +738